Quantitative assessment of cerebral blood flow in patients with Alzheimer's disease by SPECT

Journal of Nuclear Medicine

Volumn 38, Issue 7, 1997, Pages 1095-1101

  Bartenstein, Peter ^a   Minoshima, Satoshi ^b   Hirsch, Christine ^b   Buch, Katharina ^b   Willoch, Frode ^b   Mösch, Dagmar ^b   Schad, Daniel ^b   Schwaiger, Markus ^b   Kurz, Alexander ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b NONE

Author keywords

Alzheimer's disease; Cognitive dysfunction; Computer assisted image processing; SPECT

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ANALYTIC METHOD; ARTICLE; BRAIN BLOOD FLOW; COGNITION; COMPUTER ASSISTED DIAGNOSIS; DIAGNOSTIC IMAGING; FEMALE; HUMAN; IMAGE PROCESSING; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; RISK ASSESSMENT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ALZHEIMER DISEASE; CEREBROVASCULAR CIRCULATION; COGNITION; CYSTEINE; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0030877181     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Jobst KA, Hindley NJ, King E, Smith AD. The diagnosis of Alzheimer's disease: a question of image? J Clin Psychiatry 1994;55(suppl):22-31.
2. Messa C, Perani D, Lucignani G, et al. High-resolution technetium-99-m-HMPAO SPECT in patients with probable Alzheimer's disease: comparison with fluorine-18-FDG-PET. J Nucl Med 1994;35:210-216.
3. Heiss WD, Szelies B, Kessler J, Herholz K. Abnormalities of energy metabolism in Alzheimer's disease studied with PET. Ann NY Acad Sci 1991;640:65-71.
4. Osimani A, Ichise M, Chung DG, Pogue JM, Freedman M. SPECT for differential diagnosis of dementia and correlation of rCBF with cognitive impairment. Can J Neurol Sci 1994;21:104-111.
5. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 1991;82:239-259.
6. Knapp MJ, Knopman DS, Solomon PR, Pendlebury WW, Davis CS, Gracon SI. A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. J Am Med Assoc 1994;271:985-991.
7. Holman BL, Devous MD Sr. Functional brain SPECT: the emergence of a powerful clinical method. J Nucl Med 1992;33:1888-1904.
8. Waldemar G, Walowitch RC, et al. Tc-99m bicisate (Neurolite) SPECT brain imaging and cognitive impairment in dementia of the Alzheimer type: a blinded read of image sets from a multicenter SPECT trial. J Cereb Blood Flow Metab 1994;14(suppl 1):S99-S105.
9. Minoshima S, Frey KA, Koeppe RA, Foster NL, Kuhl DE. A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med 1995;36:1238-1248.
10. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimers's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-944.
11. Folstein MF, Folstein SE, McHugh PR. "Mini mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
12. Roth ET, Mountjoy CQ, Huppert FA, Hendrie H, Verma S, Goddard A. CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychol 1986;149:698-709.
13. Chang LT. A method for attenuation correction in radionuclide computed tomography. IEEE Trans Nucl Sci 1978;25:638-639.
14. Minoshima S, Berger KL, Lee KS, Mintun MA. An automated method for rotational correction and centering of three-dimensional functional brain images. J Nucl Med 1992;33:1579-1585.
15. Minoshima S, Koeppe RA, Mintun MA, et al. Automated detection of the intercom-missural line for stereotactic localization of functional brain images. J Nucl Med 1993;34:322-329.
16. Minoshima S, Koeppe RA, Frey KA, Ishihara M, Kuhl DE. Stereotactic PET atlas of the human brain: aid for visual interpretation of functional brain images. J Nucl Med 1994;35:949-954.
17. Minoshima S, Koeppe RA, Frey KA, Kuhl DE. Anatomic standardization: linear scaling and nonlinear warping of functional brain images. J Nucl Med 1994;35:1528-1537.
18. Talairach J, Tournoux P. Co-planar stereotaxic atlas of the human brain. New York: Thieme, 1988.
19. Akiyama H, Harrop R, McGeer PL, Peppard R, McGeer EG. Crossed cerebellar diaschisis and uncrossed basal ganglia and thalamic diaschisis in Alzheimer's disease. Neurology 1989;39:541-548.
20. Johnson KA, Kijewski MF, Becker A, Garada B, Satlin A, Holman BL. Quantitative brain SPECT in Alzheimer's disease and normal aging. J Nucl Med 1993;34:2044-2048.
21. O'Mahony D, Coffey J, Murphy J, et al. The discriminant value of semiquantitative SPECT data in mild Alzheimer's disease. J Nucl Med 1994;35:1450-1455.
22. Houston AS, Kemp PM, Macleod MA. A method for assessing the significance of abnormalities in HMPAO brain images. J Nucl Med 1994;35:239-244.
23. Dawson MRW, Dobbs A, Hooper HR, McEwan AJB, Triscott J, Cooney J. Artificial neuronal networks that use single-photon emission tomography to identify patients with probable Alzheimer's disease. Eur J Nucl Med 1994;21:1303-1311.
24. Lamoureux G, Dupont RM, Ashburn WL, Halpern SE. "CORT-EX": a program for quantitative analysis of SPECT data. J Nucl Med 1990;31:1862-1871.
25. Hooper HR, McEwan AJ, Lentle BC, Kothon TL, Hooper PM. Interactive three-dimensional region of interest analysis of HMPAO SPECT brain studies. J Nucl Med 1990;31:2046-2051.
26. Hashikawa K, Matsumoto M, Moriwaki H, et al. Three-dimensional display of surface cortical perfusion by SPECT: application in assessing Alzheimer's disease. J Nucl Med 1995;36:690-696.
27. Burdette JH, Minoshima S, Vander Borght T, Tran DD, Kuhl DE. Alzheimer's disease: improved visual interpretation of PET images by using three-dimensional stereotaxic surface projections. Radiology 1996;198:837-843.
28. Links JM, Devous MD Sr. Detection and comparison of patterns in images. J Nucl Med 1994;35:16-17.
29. Mielke R, Grond M, Herholz K, Kessler J, Heiss WD. Age-dependent changes of the metabolic pattern in patients with Alzheimer's disease. In: Maurer K, ed. Imaging of the brain in psychiatry and related fields. Berlin: Springer, 1993:171-176.
30. Lantos P. Ageing and dementias. In: Weller R, ed. Nervous system, muscle and eyes. Edinburgh: Churchill Livingstone, 1990.
31. O'Brien J, Eagger S, Syed GMS, Sahakian BJ, Levy R. A study of regional cerebral blood flow and cognitive performance in Alzheimer's disease. J Neurol Neurosurg Psychiatry 1992;55:1182-1187.
32. 3. Ann Neurol 1980;8:47-60.
33. Kushner M, Tobin M, Alavi A, et al. Cerebellar glucose consumption in normal and pathologic states using fluorine-18-FDG and PET. J Nucl Med 1987;28:1667-1670.
34. Talbot PR, Lloyd JL, Snowden JS, Neary D, Testa H. Choice of reference region in the quantification of single-photon emission tomography in primary degenerative dementia. Eur J Nucl Med 1994;21:503-508.
35. Saur H-B, Bartenstein P, Oberwittler C, Lerch H, Masur H, Schober O. Comparison of D2 receptor binding (I-123 IBZM) and rCBF (Tc-99m HMPAO) in extrapyramidal disorders. Nuklearmedizin 1994;33:184-188.
36. Minoshima S, Frey KA, Foster NL, Kuhl DE. Preserved pontine glucose metabolism in Alzheimer's disease: a reference region for functional brain image (PET) analysis. J Comput Assist Tomogr 1995;19:541-547.
37. Mazziotta JC, Frackowiak RSJ, Phelps ME. The use of positron emission tomography in the clinical assessment of dementia. Semin Nucl Med 1992;22:233-246.
38. Mielke R, Herholz K, Grond M, Kessler J, Heiss WD. Differences of regional cerebral glucose metabolism between presenile and senile dementia of Alzheimer type. Neurobiol Aging 1992;13:93-98.